Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2024-01-31 Capital/Financing Update
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract
Capital/Financing Update Classification · 95% confidence The document is titled "HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR H2 2023 WITH THE BROKERAGE FIRM GILBERT DUPONT". It details the activity (shares traded, cash balance) under a liquidity contract over the second half of 2023 (H2 2023), referencing the previous half-year statement (June 30, 2023). This content is a periodic report detailing financial/market operations related to share liquidity management, which is a specific type of financial disclosure. It is not a full Annual Report (10-K), a general Earnings Release (ER), or a comprehensive Interim/Quarterly Report (IR) which typically covers P&L/Balance Sheet. Since it is a specific periodic statement related to market operations, it fits best under the general category of financial/market activity reporting. Given the options, this type of periodic statement, often released to maintain market liquidity and transparency, is most closely aligned with the nature of an Interim Report (IR) if it were comprehensive, but since it is highly specific to liquidity management, and not a standard regulatory filing like 10-K or a general announcement (RNS), it is best classified as a specialized financial report. However, looking closely at the definitions, none perfectly capture a 'Liquidity Contract Statement'. It is a periodic financial disclosure. Since it covers a period shorter than a year (H2 2023), 'Interim / Quarterly Report (IR)' is the closest fit for a comprehensive periodic financial document, although this is highly specialized. If it were just an announcement of this statement, it would be RPA/RNS. Since the text contains the detailed figures, it is the report itself. Given the options, and its periodic nature covering half a year, IR is the most appropriate classification for a detailed periodic financial statement that is not the full annual report.
2024-01-31 English
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Capital/Financing Update Classification · 95% confidence The document is titled "BILAN SEMESTRIEL S2 2023 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT" (Semi-annual Balance Sheet S2 2023 of the Liquidity Contract with Gilbert Dupont Stock Brokerage Firm). It details the activity (purchases and sales of shares and cash balances) related to a liquidity contract over the second half of 2023 (S2 2023). This type of report, detailing the execution of a market-making or liquidity provision agreement, is a specific financial disclosure. It is not a full Annual Report (10-K), an Earnings Release (ER), or a standard Interim Report (IR), which focus on the company's operational results. It is a report detailing specific financial/market activities related to share trading/liquidity management. Given the provided definitions, this specialized report on liquidity management activities, which is periodic (semi-annual), fits best under the general category of financial reporting that isn't covered by the more specific codes like 10-K or IR. Since it is a detailed report of financial activity, it is not an RPA. It is a specific financial disclosure, but none of the codes perfectly match 'Liquidity Contract Report'. However, it is a detailed report of financial activity over a period. It is most closely related to periodic financial reporting. Since it is a detailed report and not just an announcement, and it is not a standard quarterly/interim report (IR) which usually covers P&L/Balance Sheet/Cash Flow, the closest fit among the options for a specific, non-standard financial report is often the general 'Regulatory Filings' (RNS) if no better fit exists, or potentially a specialized 'Audit Report/Information' (AR) if it were an internal stress test result, which it is not. Given the nature of reporting on a specific financial arrangement (liquidity contract), and lacking a specific code for 'Liquidity Report', RNS (Regulatory Filings) serves as the most appropriate fallback for a specific, non-standard periodic financial disclosure document.
2024-01-31 French
Informations privilégiées / Information sur chiffre d’affaires annuel
Earnings Release Classification · 100% confidence The document is titled with a headline announcing the company's revenue for the full year 2023 and the fourth quarter (Q4 2023). It explicitly states: 'Mauna Kea Technologies [...] publie aujourd'hui son chiffre d'affaires non audité pour le 4e trimestre et l'année 2023 clos le 31 décembre 2023.' This content—a summary of financial performance for a specific period (annual and quarterly)—is characteristic of an Earnings Release (ER). Although it contains detailed tables, the primary function is the initial announcement of results, not the comprehensive, audited report (10-K) or the detailed management discussion (MDA). Since it covers both annual and quarterly results, and is an initial release of figures, ER is the most appropriate classification. The document length (13,608 chars) is substantial, suggesting it is more than just a brief announcement (RPA), but rather the core results summary. Q4 2023
2024-01-25 French
Inside Information / Information on annual revenues
Earnings Release Classification · 100% confidence The document is titled with a headline announcing "Mauna Kea Technologies Reports Full Year 2023 Sales of €10.5m, Up +42% vs 2022". It explicitly states that the company is reporting its "unaudited sales for the fourth quarter and full year 2023, ended December 31, 2023." The content consists of key financial highlights, tables detailing sales by category and geography for Q4 and FY 2023, and commentary from the CEO. This structure is characteristic of an Earnings Release (ER), which is the initial announcement of periodical financial results, often released before the full, audited Annual Report (10-K) or comprehensive Interim Report (IR). Since it covers the full year but is presented as a press release announcing sales figures, ER is the most appropriate classification over 10-K (which is the formal SEC filing) or IR (which is typically for interim periods). FY 2023
2024-01-25 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information relative au nombre total de droits de vote et d'actions composant le capital social" (Information relative to the total number of voting rights and shares comprising the share capital) and explicitly references Article L233-8-II of the French Commercial Code and Article 223-16 of the AMF General Regulation. It provides a table detailing the number of shares in circulation and the total gross and net voting rights as of December 31, 2023. This type of mandatory periodic disclosure regarding the total share capital and voting rights structure is a specific regulatory filing requirement in France, often related to major shareholding notifications or capital structure updates, but most closely aligns with the general category for regulatory announcements that detail ownership structure changes or capital status. Given the options, this is a specific regulatory disclosure about the capital structure and voting rights, which is not explicitly covered by DVA (Voting Results), SHA (Share Issue), or MRQ (Major Shareholding Notification, which usually reports *changes* by specific entities). Since it is a formal, periodic disclosure mandated by financial regulators (AMF) detailing the capital base, it fits best under the general regulatory filing category (RNS) or potentially a specific capital/shareholding disclosure. However, since it is a formal declaration of the total voting rights count, it is a specific type of regulatory filing. Comparing the definitions, it is not an AGM-R, 10-K, ER, IR, or CT. It is a formal regulatory update on the capital structure. The closest fit among the specific options that deal with ownership structure is MRQ (Major Shareholding Notification), but this document reports the *total* capital base, not a specific shareholder crossing a threshold. Therefore, it is classified as a general Regulatory Filing (RNS) as it is a mandatory, periodic regulatory disclosure that doesn't fit the other specific categories perfectly.
2024-01-08 French
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Monthly information regarding the total number of voting rights and shares comprising the share capital" and provides a table detailing the number of shares and voting rights as of December 31, 2023. This type of regular disclosure, mandated by French commercial code (Article L233-8-II of the Commercial Code and AMF regulations), relates to the company's capital structure and ownership changes, specifically concerning voting rights. This aligns most closely with filings that report changes in significant share ownership or capital structure updates. While it is a monthly update, it is not a standard SEC form like 10-K or 10-Q. Among the provided options, 'Major Shareholding Notification' (MRQ) covers changes in significant share ownership levels, and 'Share Issue/Capital Change' (SHA) covers capital structure changes. Since this is a mandatory monthly disclosure of the total number of voting rights and shares, it is a specific type of capital/shareholder information disclosure. Given the focus on the total number of voting rights and shares, it is a direct report on the capital base, making SHA or MRQ plausible. However, MRQ is defined as 'Notification of changes in significant share ownership levels (crossing thresholds)'. This document reports the *total* capital base, which is a prerequisite for threshold calculations but is a broader capital status report. SHA is 'Announcement regarding new share issues, stock splits, or other capital changes.' Since this is a routine monthly update on the total capital base, it fits best under a general capital/shareholder information category. In the absence of a specific 'Monthly Capital Disclosure' code, and considering the content is a direct report of the capital structure, SHA is a reasonable fit, although it is often used for more active changes. Alternatively, if this is a regulatory filing that doesn't fit elsewhere, RNS could be used. Given the specific nature of reporting total voting rights, which is a key component of capital structure reporting, I will classify it as SHA, as it is a direct report on the share capital base, or MRQ if interpreted as monitoring ownership levels. Since it reports the *total* capital base rather than a specific crossing event, SHA (Share Issue/Capital Change) is slightly more appropriate as it reflects the current state of the capital structure. However, if we strictly follow the definitions, this is a routine regulatory disclosure about share capital, which often falls under general regulatory filings (RNS) if a more specific code isn't perfect. Let's re-evaluate the options: DVA is voting results. MRQ is crossing thresholds. SHA is new issues/splits. This is a routine monthly count. This type of routine disclosure often defaults to RNS if no specific code exists. But since it is explicitly about the share capital count, SHA remains a strong candidate representing the state of the capital. Given the context of financial reporting databases, routine capital structure updates are often grouped with SHA. I will select SHA as the best fit for a report detailing the total number of shares comprising the capital.
2024-01-08 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.